Active Ingredient: EMPAGLIFLOZIN; LINAGLIPTIN
Proprietary Name: GLYXAMBI
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG;5MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N206073
Product Number: 002
Approval Date: Jan 30, 2015
Applicant Holder Full Name: BOEHRINGER INGELHEIM
Marketing Status:
Prescription
Patent and Exclusivity Information
